Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Monitoring and Antagonism of Neuromuscular Blockade

Publication Date: December 15, 2022

Last Updated: January 31, 2023

Summary of Recommendations

When neuromuscular blocking drugs are administered, we recommend against clinical assessment alone to avoid residual neuromuscular blockade, due to the insensitivity of the assessment. (S, M)

Monitoring and Antagonism of Neuromuscular Blockade

Summary of Recommendations

Overview

Title

Authoring Organization